MIT spinout Ginkgo Bioworks will go public through a reverse merger with Soaring Eagle Acquisition Corp to list on the Nasdaq Capital Market.

AbbVie subsidiary Allergan Aesthetics has agreed to acquire Soliton, which is commercialising a cellulite treatment based on research at University of Texas.

The stem cell-transplant technology developer, partly based on Stanford research, is going public through a reverse merger that will give it a $490m market capitalisation.

Athenex will pay $70m upfront and up to $115m in milestone payments to acquire Kuur Therapeutics, providing exits to Baylor College and IP Group.

NeoGenomics has exercised its option to buy Inivata, a precision cancer diagnostics company that was formed to exploit Cambridge and CRUK research seven years ago.

Eddyfi/NDT has agreed to purchase UCL spinout Senceive for an undisclosed amount.

Huber+Suhner has acquired Cambridge spinout RoadMap Systems for an undisclosed amount.

Max Planck spinout The Captury has been acquired by Dari Motion for an undisclosed amount.

University of British Columbia spinout Paragon Testing Enterprises has agreed to an acquisition by Prometric Canada Testing Services.

The university-focused impact investor has acquired venture capital firm Midven to strengthen its access to scientific research in the UK.